Insider Transactions in Q2 2021 at Illumina, Inc. (ILMN)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
300
-0.69%
|
$143,400
$478.95 P/Share
|
|
Jun 24
2021
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Open market or private sale
|
Direct |
500
-10.84%
|
$237,500
$475.0 P/Share
|
|
Jun 22
2021
|
Charles Dadswell SVP, General Counsel |
SELL
Open market or private sale
|
Indirect |
314
-5.06%
|
$144,754
$461.01 P/Share
|
|
Jun 11
2021
|
Phillip G. Febbo SVP Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,000
-6.52%
|
$447,000
$447.61 P/Share
|
|
Jun 10
2021
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Open market or private sale
|
Direct |
500
-9.78%
|
$225,000
$450.0 P/Share
|
|
Jun 10
2021
|
Caroline Dorsa Director |
SELL
Open market or private sale
|
Direct |
1,000
-10.53%
|
$450,000
$450.0 P/Share
|
|
May 26
2021
|
Frances Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
881
+6.94%
|
-
|
|
May 26
2021
|
Scott Gottlieb Director |
BUY
Grant, award, or other acquisition
|
Direct |
881
+28.24%
|
-
|
|
May 26
2021
|
Philip W Schiller Director |
BUY
Grant, award, or other acquisition
|
Direct |
881
+7.46%
|
-
|
|
May 26
2021
|
John Wendell Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
881
+8.98%
|
-
|
|
May 26
2021
|
Caroline Dorsa Director |
BUY
Grant, award, or other acquisition
|
Direct |
881
+8.49%
|
-
|
|
May 26
2021
|
Robert S Epstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
881
+12.06%
|
-
|
|
May 26
2021
|
Gary S Guthart Director |
BUY
Grant, award, or other acquisition
|
Direct |
881
+10.89%
|
-
|
|
May 26
2021
|
Susan E Siegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
881
+13.6%
|
-
|
|
May 25
2021
|
Caroline Dorsa Director |
SELL
Payment of exercise price or tax liability
|
Direct |
385
-4.28%
|
$152,845
$397.09 P/Share
|
|
May 25
2021
|
Robert S Epstein Director |
SELL
Payment of exercise price or tax liability
|
Direct |
385
-6.49%
|
$152,845
$397.09 P/Share
|
|
May 25
2021
|
Gary S Guthart Director |
SELL
Payment of exercise price or tax liability
|
Direct |
385
-5.73%
|
$152,845
$397.09 P/Share
|
|
May 25
2021
|
Susan E Siegel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
385
-7.55%
|
$152,845
$397.09 P/Share
|
|
May 24
2021
|
Charles Dadswell SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
314
-4.82%
|
$126,542
$403.04 P/Share
|
|
May 20
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
500
-1.14%
|
$200,000
$400.0 P/Share
|
|
May 18
2021
|
Jay T Flatley Director |
SELL
Open market or private sale
|
Direct |
4,000
-2.62%
|
$1,516,000
$379.53 P/Share
|
|
May 05
2021
|
Jose Torres VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
793
+49.81%
|
-
|
|
May 05
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
300
-0.68%
|
$114,300
$381.88 P/Share
|
|
May 04
2021
|
Jay T Flatley Director |
SELL
Open market or private sale
|
Direct |
4,000
-2.55%
|
$1,536,000
$384.15 P/Share
|
|
Apr 22
2021
|
Charles Dadswell SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
314
-4.6%
|
$126,228
$402.02 P/Share
|
|
Apr 20
2021
|
Jay T Flatley Director |
SELL
Open market or private sale
|
Direct |
4,000
-2.49%
|
$1,604,000
$401.83 P/Share
|
|
Apr 06
2021
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,000
-8.55%
|
$424,000
$424.22 P/Share
|
|
Apr 06
2021
|
Jay T Flatley Director |
SELL
Open market or private sale
|
Direct |
4,000
-2.43%
|
$1,692,000
$423.44 P/Share
|
|
Apr 06
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
500
-1.12%
|
$211,500
$423.44 P/Share
|
|
Apr 05
2021
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,000
-14.06%
|
$386,000
$386.03 P/Share
|
|
Apr 05
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
300
-0.67%
|
$115,800
$386.03 P/Share
|
|
Apr 05
2021
|
Phillip G. Febbo SVP Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
131
-2.34%
|
$50,304
$384.54 P/Share
|